Partner
and access,
Chen Huaiwang has long been engaged in the listing, M&A, private equity financing of companies in healthcare, consumer goods, TMT, and other fields. In recent years, Mr. Chen has been involved in many Hong Kong IPO matters, such as Alphamab, Hygeia Health, Honliv Health, Zai Lab, Genor, JW Therap, Brii, Acotec, Arrail Group, Gaush Meditech. He has also served as a perennial legal advisor for many enterprises.
